Clinical Trial Update: The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA) [NA]

View source ↗

Summary

A clinical trial assessing whether PSMA PET imaging adds value for detecting clinically significant prostate cancer lesions in patients undergoing MRI-targeted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)

Snippet

Sponsor: Jules Bordet Institute | Conditions: Multiparametric MRI, Lesion PI-RADS 3 | NA | Status: RECRUITING